ArticleArthritis research & therapy2024

The dual amylin and calcitonin receptor agonist KBP-336 elicits a unique combination of weight loss, antinociception and bone protection - a novel disease-modifying osteoarthritis drug.

Khaled Elhady Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.